BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 12189445)

  • 1. Profound defects in pancreatic beta-cell function in mice with combined heterozygous mutations in Pdx-1, Hnf-1alpha, and Hnf-3beta.
    Shih DQ; Heimesaat M; Kuwajima S; Stein R; Wright CV; Stoffel M
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3818-23. PubMed ID: 11904435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased insulin sensitivity in mice lacking collectrin, a downstream target of HNF-1alpha.
    Malakauskas SM; Kourany WM; Zhang XY; Lu D; Stevens RD; Koves TR; Hohmeier HE; Muoio DM; Newgard CB; Le TH
    Mol Endocrinol; 2009 Jun; 23(6):881-92. PubMed ID: 19246514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural properties of the HNF-1A transactivation domain.
    Kind L; Driver M; Raasakka A; Onck PR; Njølstad PR; Arnesen T; Kursula P
    Front Mol Biosci; 2023; 10():1249939. PubMed ID: 37908230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HNF1A Mutations and Beta Cell Dysfunction in Diabetes.
    Miyachi Y; Miyazawa T; Ogawa Y
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HNF1A:From Monogenic Diabetes to Type 2 Diabetes and Gestational Diabetes Mellitus.
    Li LM; Jiang BG; Sun LL
    Front Endocrinol (Lausanne); 2022; 13():829565. PubMed ID: 35299962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription Control of Liver Development.
    Tachmatzidi EC; Galanopoulou O; Talianidis I
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HNF1α controls glucagon secretion in pancreatic α-cells through modulation of SGLT1.
    Sato Y; Rahman MM; Haneda M; Tsuyama T; Mizumoto T; Yoshizawa T; Kitamura T; Gonzalez FJ; Yamamura KI; Yamagata K
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165898. PubMed ID: 32711050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer.
    Kalisz M; Bernardo E; Beucher A; Maestro MA; Del Pozo N; Millán I; Haeberle L; Schlensog M; Safi SA; Knoefel WT; Grau V; de Vas M; Shpargel KB; Vaquero E; Magnuson T; Ortega S; Esposito I; Real FX; Ferrer J
    EMBO J; 2020 May; 39(9):e102808. PubMed ID: 32154941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 Diabetes-Associated Genetic Polymorphisms as Potential Disease Predictors.
    Witka BZ; Oktaviani DJ; Marcellino M; Barliana MI; Abdulah R
    Diabetes Metab Syndr Obes; 2019; 12():2689-2706. PubMed ID: 31908510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of hepatocyte nuclear factor-1α on liver malignancies and cell stemness with metabolic consequences.
    Wang X; Hassan W; Zhao J; Bakht S; Nie Y; Wang Y; Pang Q; Huang Z
    Stem Cell Res Ther; 2019 Nov; 10(1):315. PubMed ID: 31685031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte nuclear factor-1β: A regulator of kidney development and cystogenesis.
    Singh V; Singla SK; Jha V; Puri V; Puri S
    Indian J Nephrol; 2015; 25(2):70-6. PubMed ID: 25838642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An autocrine γ-aminobutyric acid signaling system exists in pancreatic β-cell progenitors of fetal and postnatal mice.
    Feng MM; Xiang YY; Wang S; Lu WY
    Int J Physiol Pathophysiol Pharmacol; 2013; 5(2):91-101. PubMed ID: 23750307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of circulating microRNAs in HNF1A-MODY carriers.
    Bonner C; Nyhan KC; Bacon S; Kyithar MP; Schmid J; Concannon CG; Bray IM; Stallings RL; Prehn JH; Byrne MM
    Diabetologia; 2013 Aug; 56(8):1743-51. PubMed ID: 23674172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional networks controlling pancreatic development and beta cell function.
    Servitja JM; Ferrer J
    Diabetologia; 2004 Apr; 47(4):597-613. PubMed ID: 15298336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of MODY3/HNF-1alpha protein in the developing mouse pancreas.
    Nammo T; Yamagata K; Hamaoka R; Zhu Q; Akiyama TE; Gonzalez FJ; Miyagawa J; Matsuzawa Y
    Diabetologia; 2002 Aug; 45(8):1142-53. PubMed ID: 12189445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cut-homeodomain transcriptional activator HNF-6 is coexpressed with its target gene HNF-3 beta in the developing murine liver and pancreas.
    Rausa F; Samadani U; Ye H; Lim L; Fletcher CF; Jenkins NA; Copeland NG; Costa RH
    Dev Biol; 1997 Dec; 192(2):228-46. PubMed ID: 9441664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone regulates the expression of hepatocyte nuclear factor-3 gamma and other liver-enriched transcription factors in the bovine liver.
    Eleswarapu S; Jiang H
    J Endocrinol; 2005 Jan; 184(1):95-105. PubMed ID: 15642787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant-negative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta-cell line.
    Wang H; Maechler P; Hagenfeldt KA; Wollheim CB
    EMBO J; 1998 Nov; 17(22):6701-13. PubMed ID: 9822613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental models of transcription factor-associated maturity-onset diabetes of the young.
    Wang H; Hagenfeldt-Johansson K; Otten LA; Gauthier BR; Herrera PL; Wollheim CB
    Diabetes; 2002 Dec; 51 Suppl 3():S333-42. PubMed ID: 12475772
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.